NewsOctober 3, 2025Boulder, CO

Aridica Corporation Completes BioTools Innovator Video Competition

Aridica Corporation is pleased to announce the successful completion of its participation in the BioTools Innovator video competition, part of the 2025 BioTools Innovator Accelerator program. Each year, BioTools Innovator companies are invited to produce short, high-impact videos to showcase their mission and technology. Aridica's one-minute video was released as part of this contest, which includes a $10,000 prize for the top submission, with winners to be announced in the coming weeks.

The video competition provides portfolio companies with global visibility, helping connect innovators with investors, partners, and industry leaders across the life sciences ecosystem.

This video milestone builds on Aridica's broader participation in the 2025 BioTools Innovator Accelerator, where the company is part of a distinguished cohort of 31 startups selected from more than 400 applicants worldwide. The program provides four months of tailored mentorship, investor exposure, and opportunities to compete for a share of $300,000 in non-dilutive cash prizes.

We are honored to share Aridica's story and vision through the BioTools Innovator video competition. This platform has given us the opportunity to clearly demonstrate our mission and technology to a global audience. We are proud of what we accomplished and look forward to the results, while also celebrating the creativity and impact of our fellow innovators.

Palani Palaniappan, CEO of Aridica Corporation

About Aridica Corporation

Aridica Corporation is a life science tools innovator dedicated to advancing immunology research through its proprietary automated PBMC separation platform. By eliminating the inefficiencies of manual processing, Aridica empowers researchers with reliable, scalable solutions that accelerate discovery and development in oncology, immunology, infectious diseases, and advanced therapies. Based in Boulder, CO, Aridica is committed to enabling breakthrough science that improves patient outcomes.